| Carrie E Flanagan, MD | |
|
420 Delaware St Se, Mmc 293, Minneapolis, MN 55455-0341 | |
| (612) 625-7634 | |
| Not Available |
| Full Name | Carrie E Flanagan |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Location | 420 Delaware St Se, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104962851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 17536 (Minnesota) | Primary |
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change' programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.
Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients.
The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.
Pfizer Inc. today announced it has signed a 10-year Provisional Supply Agreement to supply Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]), the company's 13-valent pneumococcal conjugate vaccine, for infants and young children in the world's poorest countries under the terms of the Advance Market Commitment (AMC) pilot project against pneumococcal disease.
› Verified 5 days ago
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change' programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.
Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients.
The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.
Pfizer Inc. today announced it has signed a 10-year Provisional Supply Agreement to supply Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]), the company's 13-valent pneumococcal conjugate vaccine, for infants and young children in the world's poorest countries under the terms of the Advance Market Commitment (AMC) pilot project against pneumococcal disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie E Flanagan, MD 559 Desnoyer Ave, Saint Paul, MN 55104-4917 Ph: () - | Carrie E Flanagan, MD 420 Delaware St Se, Mmc 293, Minneapolis, MN 55455-0341 Ph: (612) 625-7634 |
News Archive
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change' programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.
Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients.
The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.
Pfizer Inc. today announced it has signed a 10-year Provisional Supply Agreement to supply Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]), the company's 13-valent pneumococcal conjugate vaccine, for infants and young children in the world's poorest countries under the terms of the Advance Market Commitment (AMC) pilot project against pneumococcal disease.
› Verified 5 days ago
Jeffrey C. Manlove, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Richard M. Levinson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Robert H Maisel, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, P7, Minneapolis, MN 55415 Phone: 612-873-2424 | |
Sivakumar Chinnadurai, MD, MPH Otolaryngology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave Ste 450, Minneapolis, MN 55404 Phone: 615-813-6000 | |
Samir Suresh Khariwala, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 516 Delaware St Se, Clinic 8a, Minneapolis, MN 55455 Phone: 612-625-7400 | |
Tina Chung-ting Huang, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, University Of Minnesota Physicians, Minneapolis, MN 55455 Phone: 612-626-5900 |